BackEdesa Biotech Overview

Edesa Biotech Net Tangible Assets

Latest net tangible assets for EDSA: $12M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$12.38M

Peer average

Loading

Edesa Biotech Net Tangible Assets History

Loading

Edesa Biotech vs. peers: Net Tangible Assets Comparison

Loading

Edesa Biotech Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Edesa Biotech (EDSA) FAQ

As of the most recent data (March 2026), EDSA shows a net tangible assets of $12M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EDSA's net tangible assets is now $12M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Edesa Biotech is outperforming or lagging.

Tracking EDSA's net tangible assets over time shows whether Edesa Biotech is scaling, shrinking, or reshaping that part of the business. The current reading is $12M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Edesa Biotech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $12M) with ownership activity and broader fundamentals.

Edesa Biotech's net tangible assets is $12M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.